Skip to main content
MedPathMedPath Home
Clinical Trials/IRCT20090117001556N147
IRCT20090117001556N147
Not yet recruiting
Phase 2

Evaluating the effectiveness of citalopram and sertraline in the treatment of depression with respect to the level of BDNF, IL-6, and cortisol in men and women with major depressive disorder: A randomized double-blinded clinical trial

Tehran University of Medical Sciences0 sites80 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
Tehran University of Medical Sciences
Enrollment
80
Status
Not yet recruiting
Last Updated
3 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • •Age between 18\-60 years old
  • •Based on DSM\-V have a diagnosis of major depression (MDD) and their minimum severity of depression based on HDRS is 19

Exclusion Criteria

  • •Any other mental disorder in another axis
  • •Serious suicidal thoughts (\<2 in suicidal HDRS section)
  • •History of ECT in recent two months
  • •History of mania and hypomania
  • •Thyroid dysfunctions
  • •History of cardiovascular disease
  • •Autoimmune disorders
  • •Presence of active infection
  • •Neurologic disorders like epilepsy and Alzheimer's disease
  • •Liver disease

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Phase 2
Comparison of the efficacy of citalopram and compound of Asperugo procumbens and foeniculum vulgare in treatment of menopausal disordersMenopausal and female climacteric states.Symptoms such as flushing, sleeplessness, headache, lack of concentration, associated with menopause
IRCT2013072714174N1Vice chancellor for research, Tehran University of Medical Sciences60
Active, not recruiting
Phase 2
Evaluating treatment efficacy of citalopram, symbiotic, and mebeverine for children with functional abdominal pain.
ACTRN12613000158763Isfahan University of medical silences200
Completed
Phase 2
Effect of Olanzapine and Aripiprazole in schizophrenic patientsSchizophrenia.Schizophrenia
IRCT2013090714577N1Research deputy of Ardabil University of Medical Science80
Recruiting
Phase 2
A comparative study of the effect of citalopram in the prevention of delirium in intubated patients without brain damage in Labafinejad Hospital IC
IRCT20190215042716N6Shahid Beheshti University of Medical Sciences62
Recruiting
Phase 3
Treatment of depressive symptoms in patients with heart failureDepression.Major depressive disorder, single episode, mildF32.0
IRCT20190525043700N5Babol University of Medical Sciences80